TransCode Therapeutics Inc.

RNAZ | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.76

+$0.11 (+6.67%)

At close: Sep 21, 2026, 4:00 PM ET

$1.84

+$0.08 (+4.55%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-34.66M	-16.75M	-18.55M	-17.56M	-6.84M	-2.34M
Depreciation & Amortization	114.18K	534.86K	516.75K	98.61K	42.47K	n/a
Stock-Based Compensation	485.43K	1.7M	n/a	395.33K	186K	45.44K
Other Working Capital	968.03K	-351K	-146.27K	-174.97K	-1.85M	118.51K
Other Non-Cash Items	14.53M	1.54M	1.04M	n/a	39.47K	1.5M
Deferred Income Tax	n/a	n/a	n/a	n/a	876.19K	n/a
Change in Working Capital	15.57K	-351.48K	-1.08M	1.31M	432.39K	309.76K
Operating Cash Flow	-19.52M	-13.34M	-18.07M	-15.76M	-5.27M	-492.97K
Capital Expenditures	-6.66K	-21.76K	-35.61K	-100.92K	-254.82K	n/a
Cash Acquisitions	2.22K	n/a	n/a	n/a	3K	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-4.44K	-21.76K	-35.61K	-100.92K	-251.82K	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	1.19M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	n/a	n/a	n/a	-818.55K	-73.48K
Financial Cash Flow	31.52M	16.4M	15.91M	5.99K	25.52M	1.12M
Net Cash Flow	12M	3.04M	-2.2M	-15.86M	20M	623.55K
Free Cash Flow	-19.52M	-13.36M	-18.11M	-15.86M	-5.52M	-492.97K
Adj. Free Cash Flow	-20.01M	-15.06M	-18.11M	-16.26M	-5.71M	-538.42K
Maintenance CapEx	-6.66K	-21.76K	-35.61K	-98.61K	-42.47K	n/a
Growth CapEx	n/a	n/a	n/a	-2.31K	-212.35K	n/a
Owner Earnings	-19.52M	-13.36M	-18.11M	-15.86M	-5.31M	-492.97K